Authors

Impact of Compliance With Proton Pump Inhibitors on NSAID Treatment

Patients with gastroesophageal reflux disease who are compliant with proton pump inhibitor therapy stay on NSAIDs longer than noncompliant patients.

The Impact of Health Benefit Design on Patients With Infertility

This retrospective analysis explored the impact of infertility health benefit design on the use of infertility medications and procedures and pregnancy outcomes.

Managed Care and the Impact of Glaucoma

Barriers to Transition of Obese Patients From Hospital to Community

This study explored barriers to the transition of obese patients from hospital to community as perceived by case managers, nursing home directors, and home health directors.

Declaring War on Diabetes: New Strategies for Old Battles

AMCP Nexus 2025: Advancing Health Policy and Patient Outcomes Together

AMCP Nexus connects pharmacy leaders, drives policy change, and empowers members to enhance health care access and improve patient outcomes.

Impact of Hepatitis C Virus and Insurance Coverage on Mortality

The Medicaid population has significantly higher hepatitis C virus (HCV) prevalence and mortality rates than patients with private insurance. These data must be considered when policy makers assess providing additional support to Medicaid programs for HCV elimination.

Effects of an HMO Hospitalist Program on Inpatient Utilization

Impact of Telephonic Interventions on Glycosylated Hemoglobin and Low-density Lipoprotein Cholesterol Testing

Using Administrative Data and a Diagnosis Clustering Program to Assess Healthcare Needs of African Americans

Disparities in Physician Access for Rheumatology, Dermatology, and Gastroenterology: A Systematic Review

This article presents a systematic review of US health care disparities in physician specialist access across rheumatology, dermatology, and gastroenterology and a call to action.

Prostate Cancer

High Cost Sharing and Specialty Drug Initiation Under Medicare Part D: A Case Study in Patients With Newly Diagnosed Chronic Myeloid Leukemia

A Medicare claims analysis of patients newly diagnosed with chronic myeloid leukemia revealed that high cost sharing was associated with reduced and/or delayed tyrosine kinase inhibitor initiation under Part D.

Community-Based Asthma Education

A retrospective look at the impact of a community asthma education program reveals significant improvements in asthma management and knowledge and decreased healthcare utilization.

Cost Utility of Hub-and-Spoke Telestroke Networks From Societal Perspective

A cost-utility analysis of a hub-and-spoke telestroke network showed that it was economically dominant over routine care.

Real-Time Video Detection of Falls in Dementia Care Facility and Reduced Emergency Care

An artificial intelligence–enabled video fall detection system using visual science reduced emergency department visits by 80% in 6 communities over 3 months.

The Truth About Electronic Health Records

Why Oncologists Must Tailor Clinical Features to Their Needs

Hypertrophic Cardiomyopathy Considerations for the Managed Care Pharmacist

Human Papillomavirus and Cervical Cancer: Burden of Illness and Basis for Prevention

Emergency Department Use Associated With Primary Care Office Management

Simple office management techniques should be revisited and given focused attention by primary care physicians to limit emergency department visits for primary care“treatable conditions.

A Novel Pharmaceutical-ACO Collaboration: the Merck/Heritage Provider Network Open Innovation Challenge

Accountable care is forcing providers to develop new capacities and strategies for managing cost and quality trends. Prospectively managing the health of populations requires shifting the focus of care delivery from episodic interventions to continuous population management. As a result, accountable care organizations (ACOs) are dedicating considerable focus to developing the infrastructure and tools needed to help patients manage their chronic conditions. This is a significant departure from traditional care-delivery models and will require provider organizations to develop new partnerships and embrace new methods.

Controlling Prescription Drug Expenditures: A Report of Success

Fesoterodine: A New Agent for Treating Overactive Bladder

Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?

Understanding Meaningful Outcomes

Mechanisms to better codify clinical outcomes and intermediate outcome milestones are necessary to make the fullest use of EHR data for comparative effectiveness research.

The Employer's Perspective

Economic Implications With Newer Agents to Reduce Cardiovascular Risk in Diabetes